Evidence map›Paper›PMID 42322399›Full record

ArticleEuropean journal of nuclear medicine and molecular imaging2026

An exploratory

Chenqin Xu, Fangyang Jiao, You Ni, Zhiheng Xu, Tianyu Hu, Shiyu Li, Xiuyuan Li, Xiaoniu Liang, Jian Wang, Chuantao Zuo and 1 more

Abstract read
PubMed Publisher
In one paragraph

Article in European journal of nuclear medicine and molecular imaging, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Chenqin Xu *Department of Neurology and National Research Center for Aging and Medicine, National Center for Neurological Disorders, State Key Laboratory of Brain Function and Disorders, Huashan Hospital, Fudan University, 12 Wulumuqi Zhong Road, Shanghai, 200040, China.
Fangyang Jiao *Department of Nuclear Medicine, The First Affiliated Hospital of Chongqing Medical University, No. 1 Youyi Road, Yuzhong District, Chongqing, 400016, China.
You Ni *Department of Neurology and National Research Center for Aging and Medicine, National Center for Neurological Disorders, State Key Laboratory of Brain Function and Disorders, Huashan Hospital, Fudan University, 12 Wulumuqi Zhong Road, Shanghai, 200040, China.
Zhiheng XuDepartment of Neurology and National Research Center for Aging and Medicine, National Center for Neurological Disorders, State Key Laboratory of Brain Function and Disorders, Huashan Hospital, Fudan University, 12 Wulumuqi Zhong Road, Shanghai, 200040, China.
Tianyu HuDepartment of Neurology and National Research Center for Aging and Medicine, National Center for Neurological Disorders, State Key Laboratory of Brain Function and Disorders, Huashan Hospital, Fudan University, 12 Wulumuqi Zhong Road, Shanghai, 200040, China.
Shiyu LiDepartment of Neurology and National Research Center for Aging and Medicine, National Center for Neurological Disorders, State Key Laboratory of Brain Function and Disorders, Huashan Hospital, Fudan University, 12 Wulumuqi Zhong Road, Shanghai, 200040, China.
Xiuyuan LiDepartment of Neurology and National Research Center for Aging and Medicine, National Center for Neurological Disorders, State Key Laboratory of Brain Function and Disorders, Huashan Hospital, Fudan University, 12 Wulumuqi Zhong Road, Shanghai, 200040, China.
Xiaoniu LiangDepartment of Neurology and National Research Center for Aging and Medicine, National Center for Neurological Disorders, State Key Laboratory of Brain Function and Disorders, Huashan Hospital, Fudan University, 12 Wulumuqi Zhong Road, Shanghai, 200040, China.
Jian WangDepartment of Neurology and National Research Center for Aging and Medicine, National Center for Neurological Disorders, State Key Laboratory of Brain Function and Disorders, Huashan Hospital, Fudan University, 12 Wulumuqi Zhong Road, Shanghai, 200040, China. wangjian_hs@fudan.edu.cn.
Chuantao ZuoDepartment of Nuclear Medicine & PET Center, Huashan Hospital, Fudan University, 518 East Wuzhong Road, Shanghai, 200235, China. zuochuantao@fudan.edu.cn.
Yilin TangDepartment of Neurology and National Research Center for Aging and Medicine, National Center for Neurological Disorders, State Key Laboratory of Brain Function and Disorders, Huashan Hospital, Fudan University, 12 Wulumuqi Zhong Road, Shanghai, 200040, China. tangyilin@fudan.edu.cn.ORCID 0000-0003-2819-6554

Funding

National Health Commission of the People's Republic of China Pro20211231084249000238National Nature Science Foundation of China 82171421, 82371432, 92249302National Nature Science Foundation of China 82272039, 82021002, 82394434Natural Science Foundation of China 82371261STI2030-Major Projects 2022ZD0211606
6 · The paper itself

Abstract

purposeThe proposed body-first and brain-first Parkinson's disease (PD) subtypes are classified based on the initial localization of α-synuclein inclusions. Emerging evidence indicates the copathology of α-synuclein and tau in PD. However, the topographical pattern of tau deposition and its difference between these two phenotypes remain unclear. This study aimed to describe the tau deposits via

methodsA total of ten PD patients with presumed body-first subtypes (PDpRBD+), sixteen PD patients with presumed brain-first subtypes (PDpRBD-), and seventeen healthy controls (HCs) were enrolled. Clinical assessments and

results

conclusionOur preliminary findings demonstrated distinct

Indexed as

BrainCarbolinesParkinson DiseasePositron Emission Tomography Computed Tomographytau ProteinsAgedFemaleHumansMaleMiddle AgedCarbolinestau Proteins18F-FlorzolotauParkinson’s diseasePositron emission tomographySubtypeTau

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.